Fig. 2.: D14 simultaneously interacts with tau and PP2A.
From: Author Correction: A new tau dephosphorylation-targeting chimera for the treatment of tauopathies
f D14 reduced p-tau in a time and dose-dependent way. Significant tau-dephosphorylating efficiency was observed 24 h following administration, and at concentrations among 5–100 μM.
